XML 67 R57.htm IDEA: XBRL DOCUMENT v3.24.3
Stockholders' Equity - (Detail) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant 600,000   600,000  
Equity-based compensation expense $ (0.9) $ 3.5 $ 7.2 $ 7.0
Payment, Tax Withholding, Share-based Payment Arrangement 0.1 0.1 4.1 4.7
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount 15.8   15.8  
Share-based Payment Arrangement, Expense, Tax Benefit (0.5) 0.9 0.8 1.7
Proceeds from Stock Options Exercised 0.2 0.0 1.3 0.0
Cost of Sales [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, before Tax $ 0.6 $ 0.8 $ 1.7 $ 2.3
Restricted Stock Units (RSUs) [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of share-based awards granted     221,319  
Grant-date fair value of awards per share     $ 38.18  
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 0 120,000 0 139,000
Performance Shares [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of share-based awards granted     163,310  
Grant-date fair value of awards per share     $ 40.17  
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 0 94,000 0 112,000